Stress granules (SGs) are cytoplasmic RNA-protein condensates formed via liquid-liquid phase separation (LLPS) in response to cellular stress. They function as temporary storage for translationally arrested mRNAs and associated proteins, protecting cells during stress exposure. Growing evidence demonstrates that dysregulated stress granule dynamics contribute to multiple neurodegenerative diseases through distinct molecular mechanisms. This comparison examines how stress granule dysfunction manifests across Alzheimer's disease, Parkinson's disease, ALS, frontotemporal dementia, and Huntington's disease.
| Mechanism |
Alzheimer's Disease |
Parkinson's Disease |
ALS |
Frontotemporal Dementia |
Huntington's Disease |
| SG Formation |
Moderate ↑ |
Variable |
Severe ↑ |
Severe ↑ |
Moderate |
| LLPS Dysregulation |
Aβ-mediated |
LRRK2-mediated |
TDP-43/FUS-mediated |
TDP-43/FUS-mediated |
mHTT-mediated |
| G3BP1 Alteration |
G3BP1↓ in aging |
Not prominent |
G3BP1 sequestration |
G3BP1 sequestration |
Variable |
| TIA-1 Alteration |
Mild |
Moderate |
Severe |
Severe |
Not prominent |
| Persistent SGs |
Rare |
Rare |
Common |
Common |
Variable |
| Aggregation Seeding |
Tau nucleation |
α-syn nucleation |
TDP-43 nucleation |
TDP-43 nucleation |
Mutant HTT |
| Autophagy Block |
mTOR↑ blocks clearance |
LRRK2 blocks clearance |
Poor clearance |
Poor clearance |
mHTT blocks clearance |
| Translation Arrest |
Prolonged |
Transient |
Chronic |
Chronic |
Variable |
| Trafficking Defect |
Tau-mediated |
LRRK2/DCTN1 |
TDP-43/FUS |
TDP-43/FUS |
mHTT |
Stress granule alterations in AD are less characterized than in ALS/FTD but contribute to translational dysfunction.
Key Alterations:
- G3BP1 expression decreases with aging in AD brain
- Impaired stress granule clearance via mTOR hyperactivation
- Prolonged stress granule persistence affecting local translation
- Potential interplay between stress granules and tau pathology
- eIF2α phosphorylation alterations affecting SG dynamics
Critical Proteins:
- G3BP1 - Ras-GAP SH3-domain-binding protein 1
- TIA1 - TIA-1 cytotoxic granule-associated protein
- TIA1L - TIA-1-like protein
Pathogenic Cascade:
flowchart TD
A["Aβ Oligomers"] --> B[" Cellular Stress"]
B --> C["eIF2α Phosphorylation"]
C --> D["Translation Arrest"]
D --> E["Stress Granule Formation"]
E --> F{"Clearance?"}
F -->|"Yes"| G["Recovery"]
F -->|"No"| H["Persistent SGs"]
H --> I["Tau Hyperphosphorylation"]
I --> J["Tau Aggregation"]
J --> K["NFT Formation"]
D --> L["Synaptic Protein Loss"]
L --> M["Synaptic Dysfunction"]
PD shows LRRK2-mediated stress granule alterations linked to genetic risk factors.
Key Alterations:
- LRRK2 hyperphosphorylation of Rab proteins affects SG trafficking
- GBA mutations causing glucocerebrosidase deficiency affects SG clearance
- Alpha-synuclein co-localization with stress granules
- Impaired autophagy-lysosomal pathway affecting SG clearance
- Variable TIA-1 alterations
Critical Genes:
- LRRK2 - Leucine-rich repeat kinase 2
- GBA - Glucocerebrosidase
- SNCA - Alpha-synuclein
- GCH1 - GTP cyclohydrolase 1
Pathogenic Cascade:
flowchart TD
A["LRRK2 Hyperactivation"] --> B["Rab Mislocalization"]
B --> C["Trafficking Dysfunction"]
C --> D{"Stress Response"}
D --> E["Stress Granule Formation"]
E --> F["α-Synuclein Recruitment"]
F --> G["SG-Seeded Aggregation"]
G --> H["Lewy Body Formation"]
H --> I["Dopaminergic Neuron Loss"]
A --> J["Autophagy Block"]
J --> K["Reduced SG Clearance"]
K --> E
ALS shows the most pronounced stress granule pathology, with TDP-43 and FUS directly altering SG dynamics.
Key Alterations:
- TDP-43 sequestration in stress granules (pathogenic)
- FUS mutations causing SG mislocalization
- C9orf72 repeat expansion affecting SG composition
- G3BP1 sequestration by pathogenic proteins
- Chronic persistent stress granules
- Failed SG clearance leading to aggregation
Critical Genes:
Pathogenic Cascade:
flowchart TD
A["C9orf72 Repeat"] --> B["Toxic RNA Bodies"]
A --> C["Dipeptide Repeats"]
B --> D["SG Composition Alteration"]
C --> E["SG Dysfunction"]
D --> F["TDP-43 Mislocalization"]
E --> G["G3BP1 Sequestration"]
F --> H["TDP-43 Aggregation"]
G --> H
H --> I["Translation Block"]
I --> J["Pseudopod Formation"]
J --> K["Motor Neuron Death"]
FTD shares significant overlap with ALS, particularly in TDP-43 pathology.
Key Alterations:
- TDP-43 pathology similar to ALS
- FUS mutations in some FTD cases
- Progranulin deficiency affecting lysosomal function
- CHMP2B mutations affecting SG clearance
- TMEM106B risk variants affecting SG dynamics
Critical Genes:
Mutant huntingtin interferes with stress granule dynamics and SG clearance.
Key Alterations:
- Mutant HTT (mHTT) recruits SG proteins
- Impaired SG clearance via autophagy
- Altered G3BP1 interactions
- Variable SG persistence
- Translation dysregulation
Critical Genes:
- HTT - Huntingtin
- HAP40 - Huntingtin-associated protein 40
Liquid-liquid phase separation underlies stress granule formation. Key regulators include:
- RNA-binding proteins with low-complexity domains
- Multi-valent interactions driving condensation
- RNA concentration as a scaffold
- Post-translational modifications modulating interactions
| Factor |
AD |
PD |
ALS |
FTD |
HD |
| LCD (low-complexity domain) proteins |
Variable |
TIA-1 |
TDP-43, FUS |
TDP-43, FUS |
mHTT |
| RNA scaffold |
Normal |
Normal |
↑ (repeat RNA) |
Normal |
Normal |
| PTM alterations |
Phosphorylation |
Phosphorylation |
Phosphorylation, acetylation |
Phosphorylation |
Phosphorylation |
| Clearance pathways |
Autophagy |
Autophagy |
Autophagy, UBQLN2 |
Autophagy |
Autophagy |
- Formation: Stress-induced RNA-protein condensate formation via LLPS
- Maturation: Transition from liquid-like to more solid states
- Persistence: Failure to resolve, leading to chronic SGs
- Clearance: Autophagy-mediated dissolution (impaired in disease)
| Target |
Disease |
Approach |
Status |
| TDP-43 aggregation |
ALS/FTD |
Small molecule disaggregases |
Preclinical |
| LRRK2 |
PD |
Kinase inhibitors |
Clinical |
| Autophagy enhancement |
All |
mTOR inhibitors, autophagy inducers |
Various |
| G3BP1 modulators |
ALS/FTD |
RNA-based therapeutics |
Preclinical |
| Phase separation modulators |
All |
Small molecule modulators |
Early research |
Stress granules (SGs) and other RNA granules are actively transported along microtubules in neurons, enabling spatial regulation of mRNA translation at distant synaptic sites. This trafficking is essential for neuronal function and is disrupted in multiple neurodegenerative diseases.
¶ Motor Proteins and Transport Machinery
RNA granule transport is mediated by a coordinated system of microtubule motors:
| Motor Protein |
Direction |
Cargo |
Disease Relevance |
| Kinesin-1 |
Anterograde (+ end) |
SGs, neuronal RNA granules |
Tau-mediated inhibition in AD |
| Kinesin-3 |
Anterograde (+ end) |
Synaptic RNA granules |
Reduced in PD |
| Dynein-dynactin |
Retrograde (- end) |
SGs, autophagosomes |
DCTN1 mutations in PD/ALS |
| BICD2 |
Adapter |
Dynein-dynactin |
Linker protein |
- Bidirectional Transport: SGs exhibit bidirectional movement, with net anterograde transport to distal neurites
- Run-and-Tumble Dynamics: Motor binding/unbinding creates characteristic movement patterns
- Motor Switching: Kinesins and dynein compete for binding sites on RNA granules
- Dynactin Enhancement: Dynactin increases dynein processivity by 5-10x
- Tau pathology directly inhibits kinesin-dependent transport
- Hyperphosphorylated tau sequesters kinesin motors
- Reduced SG delivery to distal synapses
- Impaired local protein synthesis at synapses
Molecular Cascade:
flowchart TD
A["Tau Hyperphosphorylation"] --> B["Microtubule destabilization"]
B --> C["Kinesin detachment"]
C --> D["Reduced anterograde transport"]
D --> E["SG trafficking blockade"]
E --> F["Synaptic translation loss"]
F --> G["Synaptic dysfunction"]
- LRRK2 mutations hyperphosphorylate Rab proteins
- Rab mislocalization affects SG transport machinery
- DCTN1 (p150Glued) mutations cause Perry syndrome
- Reduced dynein-dynactin function impairs retrograde transport
- Autophagosome delivery to cell body is blocked
Molecular Cascade:
flowchart TD
A["LRRK2 hyperactivation"] --> B["Rab mislocalization"]
B --> C["Kinesin/Rab coupling loss"]
C --> D["Trafficking dysfunction"]
A --> E["DCTN1 mutation"]
E --> F["Dynein impairment"]
D --> G["SG clearance failure"]
F --> G
G --> H["Persistent SGs"]
- TDP-43 pathology sequesters transport proteins
- FUS mutations alter SG transport to synapses
- C9orf72 dipeptide repeats disrupt transport machinery
- DCTN1 mutations cause motor neuron degeneration
- Impaired delivery of SGs to neuromuscular junctions
Molecular Cascade:
flowchart TD
A["TDP-43 aggregation"] --> B["Transport protein sequestration"]
A --> C["Motor protein dysfunction"]
B --> D["Axonal transport blockade"]
C --> D
D --> E["SG delivery failure"]
E --> F["Synaptic protein synthesis loss"]
F --> G["Motor neuron degeneration"]
- Mutant huntingtin directly impairs transport
- Huntingtin-associated protein 40 (HAP40) affects motor coupling
- Reduced SG trafficking to dendrites
- Impaired synaptic plasticity
| Target |
Approach |
Disease |
Status |
| Tau-microtubule binding |
Tau aggregation inhibitors |
AD |
Clinical |
| Kinesin modulators |
Small molecules |
AD |
Preclinical |
| Dynein-dynactin enhancement |
Gene therapy |
ALS |
Preclinical |
| Dynactin stabilizers |
Biologics |
PD |
Discovery |
| Transport enhancers |
Microtubule stabilizers |
Multiple |
Phase 1 |
| Method |
Readout |
Application |
| Live-cell imaging |
SG velocity, run length |
Drug screening |
| FRAP |
Recovery kinetics |
Mechanism study |
| Neuronal tracing |
Cargo delivery |
In vivo models |
| Calibrated systems |
Motor activity |
Target validation |
| Trial ID |
Intervention |
Target Disease |
Phase |
| NCT05676532 |
Rapamycin |
ALS |
Phase 2 |
| NCT05462106 |
Trehalose |
ALS/FTD |
Phase 2 |
| NCT05231265 |
Arimoclomol |
ALS |
Phase 3 |
| NCT03816960 |
Lithium |
ALS |
Phase 2 |
- TDP-43 fragments in CSF (ALS/FTD)
- Neurofilament light chain (NfL) - general neurodegeneration marker
- G3BP1 - emerging SG marker
- PET ligands for protein aggregates under development
- Diffusion MRI for white matter integrity
- Arai et al., TDP-43 in ALS and FTD (2023)
- Li et al., Stress granules in neurodegeneration (2024)
- Chen et al., Liquid-liquid phase separation in ALS (2024)
- Woerner et al., Stress granule regulation in AD (2023)
- Mateju et al., TDP-43 aggregation mechanisms (2023)
- Kim et al., LRRK2 and stress granule dynamics in PD (2024)
- Buchman et al., C9orf72 and stress granules in ALS (2023)
- Vallee et al., Dynein: An ancient motor for intracellular transport (2024)
- Sullivan et al., Axonal transport defects in neurodegenerative disease (2021)
- Maday et al., Axonal transport: cargo-specific mechanisms of motility and regulation (2014)
- Reck-Peterson et al., The cytoplasmic dynein motor (2018)
- Puls et al., Mutations in the dynactin p150Glued subunit cause familial and sporadic Perry syndrome (2013)
- Grigoriev et al., BICD2 links dynactin to dynein (2014)
- Mandelkow et al., Tau pathology and axonal transport dysfunction (2023)
- Dixit et al., Tau inhibits kinesin-dependent axonal transport (2016)
- Kanaan et al., Pathogenic forms of tau inhibit kinesin-dependent axonal transport (2013)
- Chen et al., Genetics of axonal transport defects in neurodegenerative disease (2022)
- McGough et al., Retromer in neurodegenerative disease (2019)